Editorial: Nonsteroidal anti-inflammatory drugs for prophylaxis of acute anterior uveitis

Ocular Immunology and Inflammation

Volumn 18, Issue 2, 2010, Pages 69-71

  Levinson, Ralph D ^a   Rosenbaum, James T ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acute anterior uveitis; Acute iritis; HLA B27; NSAID; Uveitis

Indexed keywords

ADALIMUMAB; CELECOXIB; CORTICOSTEROID; DIFLUNISAL; ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR;

DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HUMAN; IRIDOCYCLITIS; PROGNOSIS; RECURRENT DISEASE; RISK; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; TREATMENT OUTCOME; ACUTE DISEASE; FEMALE; MALE; NOTE;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; RECURRENCE; UVEITIS, ANTERIOR;

EID: 77950582888     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273941003768224     Document Type: Editorial

References (9)

1. Fiorelli V, Bath P, Foster C. Non-steroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm. 2010 (same issue);18.
2. Monnet D, Breban M, Hudry C, Dougados M, Brézin AP. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004;111:802-809.
3. Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol. 2005;139:900-905.
4. Agnani S, Choi D, Martin T, et al. Gender and laterality affect recurrences of acute anterior uveitis. Br J Ophthalmol. 2010 (in press).
5. Muñoz-Fernández S, Hidalgo V, Fernández-Melón J, et al. Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol. 2003;30:1277-1279.
6. Muñoz-Fernández S, García-Aparicio AM, Hidalgo MV, et al. Methotrexate: an option for preventing the recurrence of acute anterior uveitis. Eye (Lond.) 2009;23:1130-1133.
7. Sieper J, Koenig A, Baumgartner S. et al. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials. Ann Rheum Dis 2010;69:226-229.
8. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005;52:2447-2451.
9. Rudwaleit M, Rødevand E, Holck P. et al. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis. 2009; 68:696-701.